EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Comment on Kaminski et al. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes. Diabetes Care 2024;47:267–271

Ray Wang iD, Rahul D Barmanray iD, Mervyn Kyi iD, Spiros Fourlanos iD

Diabetes Care · 2024

DOI: 10.2337/dc24-0586 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Diabetes Care, 2024. Verfasst von Ray Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes and Endocrinology, The Royal Melbourne Hospital, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Glycated Hemoglobin, Glycated Serum Albumin, Glycation End Products, Advanced, Fructosamine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: University of Melbourne, Australian Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycated HemoglobinGlycated Serum AlbuminGlycation End Products, AdvancedFructosamineBlood GlucoseSerum AlbuminKidney Failure, ChronicHumansGlycemic ControlBlood Glucose Self-MonitoringDiabetes MellitusContinuous Glucose Monitoring

Substanzen

Glycated HemoglobinGlycated Serum AlbuminGlycation End Products, AdvancedFructosamineBlood GlucoseSerum Albumin

Autor:innen und Institutionen

  • Department of Diabetes and Endocrinology, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Department of Medicine (Royal Melbourne Hospital), The University of Melbourne, Parkville, Victoria, Australia.
  • Australian Centre for Accelerating Diabetes Innovations (ACADI), The University of Melbourne, Parkville, Victoria, Australia.

ORCID-Profile: Ray Wang, Rahul D Barmanray, Mervyn Kyi, Spiros Fourlanos

Förderung

  • University of Melbourne
  • Australian Government

Zitieren

APA

Wang, R., Barmanray, R. D., Kyi, M., & Fourlanos, S. (2024). Comment on Kaminski et al. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes. Diabetes Care 2024;47:267–271. Diabetes Care. https://doi.org/10.2337/dc24-0586

Vancouver

Wang R, Barmanray RD, Kyi M, Fourlanos S. Comment on Kaminski et al. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes. Diabetes Care 2024;47:267–271. Diabetes Care. 2024. doi:10.2337/dc24-0586

BibTeX
@article{Wang2024,
  author = {Wang, Ray and Barmanray, Rahul D and Kyi, Mervyn and Fourlanos, Spiros},
  title = {Comment on Kaminski et al. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes. Diabetes Care 2024;47:267–271},
  journal = {Diabetes Care},
  year = {2024},
  doi = {10.2337/dc24-0586}
}
Kostenlos starten →